David Othman
Procedural Dermatology · Chicago, ILNPI 1760741938
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 142 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,117 and has fallen 88.6% since, to $242 in 2025.
Across 142 payments — averaging $34.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$962
- Galderma Laboratories, L.p.$924
- AbbVie$765
- Regeneron Healthcare Solutions, Inc.$416
- Sanofi$254
- Novartis$246
- plus $1K from 15 others
Across 30 payments — averaging $4208.79 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Teva Pharmaceuticals USA, Inc.$80K
- GSK$36K
- Sanofi Pasteur Inc.$10K
What the payments were for
- Travel & lodging$230%
- Food & beverage$4,894100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 38 | $962 |
| Galderma Laboratories, L.p. | 18 | $924 |
| AbbVie | 20 | $765 |
| Regeneron Healthcare Solutions, Inc. | 12 | $416 |
| Sanofi | 5 | $254 |
| Novartis | 9 | $246 |
| Johnson & Johnson | 4 | $194 |
| UCB, Inc. | 2 | $177 |
| Almirall LLC | 2 | $150 |
| Bristol Myers Squibb | 4 | $143 |
| VYNE Pharmaceuticals Inc. | 1 | $141 |
| Mayne Pharma Commercial LLC | 6 | $131 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $118 |
| LEO Pharma Inc. | 5 | $88 |
| Aclaris Therapeutics, Inc. | 3 | $52 |
| Amgen | 2 | $35 |
| Sun Pharmaceutical Industries Inc. | 2 | $31 |
| Mission Pharmacal Company | 1 | $27 |
| EPI Health, LLC | 2 | $26 |
| Journey Medical Corporation | 1 | $21 |
| Pfizer | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few procedural dermatology providers in Illinoisto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 12 | $153 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Chicago
- Valeria FugaliChicago$456
- Charles ZugermanChicago$420
- Ashish BhatiaItasca$434K
- Keith KozenyBuffalo Grove$178K
- Scott GlazerBuffalo Grove$38K
- Michael FretzinBuffalo Grove$22K
- Amy BrodskyRockford$21K
- Kent TaulbeeBloomington$544
- David FretzinPark Ridge$207
- Raymond VahlWorth$136
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.